Activation of the clotting system:: heparin-coated versus non coated systems for extracorporeal circulation

被引:27
作者
Urlesberger, B
Zobel, G
Rödl, S
Dacar, D
Friehs, I
Leschnik, B
Muntean, W
机构
[1] Graz Univ, Kinderklin, ECMO Ctr Graz, Dept Neonatol, A-8036 Graz, Austria
[2] Graz Univ, ECMO Ctr Graz, Dept Gen Pediat, A-8036 Graz, Austria
[3] Graz Univ, ECMO Ctr Graz, Dept Cardiac Surg, A-8036 Graz, Austria
关键词
extracorporeal membrane oxygenation; animal experiment; heparin-coated circuit; clotting activation;
D O I
10.1177/039139889702001211
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The purpose of this experimental study was to compare heparin-coated versus noncoated systems for extracorporeal membrane oxygenation (ECMO), to investigate the dynamic course of clotting activation in both groups. Methods. Eight pigs weighing 19.7 (+/- 1.3) kg, each underwent ECMO for 24 hours. Two groups were formed: in group 1, heparin-coated circuits were used with low dose heparinization (10 IU/kg/hr), whereas in group 2 non-coated circuits with high dose heparinization (60 IU/kg/hr) were used Coagulation was monitored by measuring prothrombin time, partial thromboplastin time, fibrinogen, antithrombin III (AT III) and specific markers of clotting activation (thrombin-antithrombin III complexes (TAT) and D-dimer). Furthermore, platelet count, hematocrit, activated clotting time (ACT), and plasma heparin concentration were determined regularly. Results. The dynamic course of the specific coagulation activation markers showed some differences: whereas TAT and D-dimer increased quickly in group 2, the increase in group 1 was delayed. Activation marker Values tended to be fewer in group I during the first six hours, alter which no more differences between the groups were seen. After 24 hours of ECMO, TAT and D-dimer had nearly returned to baseline values. Platelets showed a continuous decrease throughout the experiment, which was very similar in both groups. Conclusions. The heparin coated system showed a distinct delay in clotting activation during the first six hours of ECMO. After six hours there were no more differences between the groups.
引用
收藏
页码:708 / 712
页数:5
相关论文
共 14 条
[1]  
BOROWIEC J, 1992, J THORAC CARDIOV SUR, V104, P642
[2]   PLATELET AND NEUTROPHIL ACTIVATION IN CARDIOPULMONARY BYPASS [J].
COLMAN, RW .
ANNALS OF THORACIC SURGERY, 1990, 49 (01) :32-34
[3]  
ELGUE G, 1993, THROMB HAEMOSTASIS, V70, P289
[4]   SAFE USE OF HEPARIN-COATED BYPASS CIRCUITS INCORPORATING A PUMP-OXYGENATOR [J].
JONES, DR ;
HILL, RC ;
VASILAKIS, A ;
HOLLINGSED, MJ ;
GRAEBER, GM ;
GUSTAFSON, RA ;
CRUZZAVALA, JL ;
MURRAY, GF .
ANNALS OF THORACIC SURGERY, 1994, 57 (04) :815-819
[5]   PROGRESS IN VENOVENOUS LONG-TERM BYPASS TECHNIQUES FOR THE TREATMENT OF ARDS - CONTROLLED CLINICAL-TRIAL WITH THE HEPARIN-COATED BYPASS CIRCUIT [J].
KNOCH, M ;
KOLLEN, B ;
DIETRICH, G ;
MULLER, E ;
MOTTAGHY, K ;
LENNARTZ, H .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1992, 15 (02) :103-108
[6]   24-HOUR HEPARIN-FREE VENO RIGHT VENTRICULAR ECMO - AN EXPERIMENTAL-STUDY [J].
KOUL, B ;
VESTERQVIST, O ;
EGBERG, N ;
STEEN, S .
ANNALS OF THORACIC SURGERY, 1992, 53 (06) :1046-1051
[7]   A NEW NON-THROMBOGENIC SURFACE PREPARED BY SELECTIVE COVALENT BINDING OF HEPARIN VIA A MODIFIED REDUCING TERMINAL RESIDUE [J].
LARM, O ;
LARSSON, R ;
OLSSON, P .
BIOMATERIALS MEDICAL DEVICES AND ARTIFICIAL ORGANS, 1983, 11 (2-3) :161-173
[8]  
Mottaghy K, 1989, ASAIO Trans, V35, P635, DOI 10.1097/00002480-198907000-00152
[9]  
Mottaghy K, 1989, ASAIO Trans, V35, P146, DOI 10.1097/00002480-198904000-00006
[10]  
OVRUM E, 1995, CIRCULATION, V92, P2579